Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Chinese astronauts’ return to Earth delayed over fears spaceship damaged by debris - 2South Korea launches Earth-observation satellite on homegrown Nuri rocket
- 3IndiGo lands IATA chief Willie Walsh as new CEO
- 4Germany's first Omani LNG shipments arrive despite Middle East disruptions
- 5Eleven Creations And Developments That Steered History
- 4 Creative Savvy Home Gadgets of 2024: Reforming Home Robotization and Security
- Here's what can happen if you drive under the influence of pot
- 'Crammed into a cell with vermin at New Year'
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Woman leaves bachelorette trip after trusting her gut about sketchy men partying it up with friends
- the Wild in Style: The Reduced Portage Mustang's Bold Heritage
- This Tiny Bright Yellow Frog Is One of the Most Toxic Animals on Earth
- The Best Games Crossroads in History
- Every year, she thanks the trooper for the arrest that led to her sobriety
